Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock

Stock Information for Titan Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Titan Pharmaceuticals Inc.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCS, HLVX, BSGM, TTNP on Behalf of Shareholders
TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS, VBTX, TTNP on Behalf of Shareholders July 31, 2025
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Titan Pharmaceuticals, Inc. (TTNP)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE, SPTN, TTNP on Behalf of Shareholders
URGENT: The M&A Class Action Firm Encourages $hareholders to Act Before Vote - Titan Pharmaceuticals, Inc. (Nasdaq: TTNP)
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate Merger of TTNP, BASE, SPTN, and CFSB
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CARM, ENZB, HSON, TTNP on Behalf of Shareholders

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.